Two major drug trials concluded there was little risk from a drug aimed at age-related macular degeneration. Yet an ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye.
CILS-9100 cap and tube label sets consist of multiple CILS label shapes and sizes on a single roll/letter size sheet allowing variable data printing (batch numbers, barcodes) inlab, straight from your standard laser or thermal transfer printer.
GE Healthcare’s ExoStar kit supports researchers by providing a high performance and cost effective product for the enzymatic removal of unincorporated primers and nucleotides from PCR and sequencing reactions.
Almac is expanding manufacturing capacity at its European headquarters to over 30 m3. The upgraded facility will include reactor vessels with clean room product isolation and drying equipment to allow API manufacture up to a 600 kg batch size.
Merck announced results from two 26-week investigational Phase 3 clinical studies evaluating the efficacy and safety of two dose strengths of Dulera in adults 40 years and older with moderate to very severe chronic obstructive pulmonary disease.
The Vysis EGR1 FISH Probe Kit can help physicians determine which patients can be treated with chemotherapy, the first option for AML, and who has more severe disease and may require a stem cell transplant.
Federal health officials approved the first generic versions of the blockbuster drug Zyprexa, an expensive treatment for schizophrenia and bipolar mood disorder.
Federal health officials said that Pfizer's anti-smoking drug Chantix did not increase psychiatric problems like depression and suicidal thoughts in two studies, though the findings are not definitive.
Momenta Pharmaceuticals Inc. said that its partner Sandoz's launch of a generic version of the blood thinner Lovenox will trigger royalty payments when Sandoz starts selling the drug during the fourth quarter.
Swiss pharmaceutical giant Novartis AG said it will cut 2,000 jobs as drug prices come under pressure from governments seeking to reduce health care budgets.
For modern biologists, the ability to capture high-quality, three-dimensional images of living tissues or organisms over time is necessary to answer problems in areas ranging from genomics to neurobiology and developmental biology.
Researchers at Albert Einstein College of Medicine developed the first fluorescent protein that enables scientists to see the internal organs of living animals without the need for a scalpel.
A series of novel imaging agents could make it possible to "see" tumors in their earliest stages, before they turn deadly.
Prasco Laboratories signed a marketing and distribution agreement with Eli Lilly and Company to market the generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets.